Biotage AB (Biotage AB) Long-Term Debt : $28.1 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Long-Term Debt?

Biotage AB's Long-Term Debt for the quarter that ended in Mar. 2024 was $28.1 Mil.

Biotage AB's quarterly Long-Term Debt declined from Sep. 2023 ($27.7 Mil) to Dec. 2023 ($14.6 Mil) but then increased from Dec. 2023 ($14.6 Mil) to Mar. 2024 ($28.1 Mil).

Biotage AB's annual Long-Term Debt declined from Dec. 2021 ($16.5 Mil) to Dec. 2022 ($14.5 Mil) but then increased from Dec. 2022 ($14.5 Mil) to Dec. 2023 ($14.6 Mil).

Biotage AB Long-Term Debt Historical Data

The historical data trend for Biotage AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Long-Term Debt Chart

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

18.91

13.15

16.50

14.45

14.62

Biotage AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															14.32	28.42	27.70	14.62	28.14

Biotage AB (OTCPK:BITGF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biotage AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biotage AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.